source
- Biogen's low-dose tau drug shows greater slowing of Alzheimer’s progression after two yearsBiogen reported new data on its experimental tau-reducing therapy diranersen, showing that the lowest dose continued to slow Alzheimer’s disease progression after nearly two years of treatment. Th…
- White House withdraws Trump nominee Heidi Overton from FDA commissioner consideration amid Senate doubtsThe White House announced it has pulled Heidi Overton, the Trump administration’s nominee to serve as commissioner of the Food and Drug Administration. Overton’s nomination had been moving through…